Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070)
Saudi Arabia
· Delayed Price · Currency is SAR 26.25
+0.10 (0.38%)
Mar 27, 2025, 3:17 PM AST
TADAWUL:2070 Income Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 1,682 | 1,653 | 1,422 | 1,460 | 1,555 | Upgrade
|
| Revenue Growth (YoY) | 1.75% | 16.27% | -2.60% | -6.14% | 4.60% | Upgrade
|
| Cost of Revenue | 845 | 958.47 | 864.5 | 846.73 | 869.96 | Upgrade
|
| Gross Profit | 837 | 694.61 | 557.31 | 613.05 | 685.32 | Upgrade
|
| Selling, General & Admin | 604 | 602.02 | 620.63 | 551.26 | 530.74 | Upgrade
|
| Research & Development | 76 | 41.46 | 42.65 | 29.07 | 20.35 | Upgrade
|
| Other Operating Expenses | 19 | -59.55 | -7.93 | 13.74 | -10.98 | Upgrade
|
| Operating Expenses | 699 | 597.65 | 665.39 | 580.22 | 541.58 | Upgrade
|
| Operating Income | 138 | 96.96 | -108.08 | 32.83 | 143.75 | Upgrade
|
| Interest Expense | -65 | -59.23 | -34.33 | -31.4 | -33.61 | Upgrade
|
| Interest & Investment Income | - | - | - | - | 7 | Upgrade
|
| Earnings From Equity Investments | - | 20 | 20.44 | 11.41 | 38.21 | Upgrade
|
| Currency Exchange Gain (Loss) | - | -4.32 | -14.38 | 15.03 | -0.47 | Upgrade
|
| Other Non Operating Income (Expenses) | -1 | -3.17 | - | -1.49 | 0.3 | Upgrade
|
| EBT Excluding Unusual Items | 72 | 50.23 | -136.35 | 26.38 | 155.18 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | 0.04 | 3.63 | 7.81 | 3.52 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 6.38 | 0.14 | -0.45 | - | Upgrade
|
| Legal Settlements | - | -20.47 | - | - | - | Upgrade
|
| Pretax Income | 72 | 36.18 | -132.59 | 33.73 | 158.7 | Upgrade
|
| Income Tax Expense | 40 | 45.26 | 25.9 | 12.35 | 43.9 | Upgrade
|
| Earnings From Continuing Operations | 32 | -9.08 | -158.48 | 21.38 | 114.81 | Upgrade
|
| Earnings From Discontinued Operations | - | 6.49 | -12.75 | -3.28 | -5.26 | Upgrade
|
| Net Income to Company | 32 | -2.59 | -171.23 | 18.1 | 109.54 | Upgrade
|
| Minority Interest in Earnings | - | -11.12 | 6.1 | 8.35 | 15.25 | Upgrade
|
| Net Income | 32 | -13.71 | -165.14 | 26.45 | 124.79 | Upgrade
|
| Net Income to Common | 32 | -13.71 | -165.14 | 26.45 | 124.79 | Upgrade
|
| Net Income Growth | - | - | - | -78.80% | - | Upgrade
|
| Shares Outstanding (Basic) | 120 | 120 | 120 | 120 | 120 | Upgrade
|
| Shares Outstanding (Diluted) | 120 | 120 | 120 | 120 | 120 | Upgrade
|
| Shares Change (YoY) | 0.03% | -0.03% | - | - | - | Upgrade
|
| EPS (Basic) | 0.27 | -0.11 | -1.38 | 0.22 | 1.04 | Upgrade
|
| EPS (Diluted) | 0.27 | -0.11 | -1.38 | 0.22 | 1.04 | Upgrade
|
| EPS Growth | - | - | - | -78.80% | - | Upgrade
|
| Free Cash Flow | -398 | -63.68 | -177.51 | 10.47 | -155.02 | Upgrade
|
| Free Cash Flow Per Share | -3.32 | -0.53 | -1.48 | 0.09 | -1.29 | Upgrade
|
| Dividend Per Share | - | - | - | 0.600 | 1.000 | Upgrade
|
| Dividend Growth | - | - | - | -40.00% | - | Upgrade
|
| Gross Margin | 49.76% | 42.02% | 39.20% | 42.00% | 44.06% | Upgrade
|
| Operating Margin | 8.21% | 5.87% | -7.60% | 2.25% | 9.24% | Upgrade
|
| Profit Margin | 1.90% | -0.83% | -11.61% | 1.81% | 8.02% | Upgrade
|
| Free Cash Flow Margin | -23.66% | -3.85% | -12.48% | 0.72% | -9.97% | Upgrade
|
| EBITDA | 223 | 161.53 | -28.21 | 112.57 | 222.17 | Upgrade
|
| EBITDA Margin | 13.26% | 9.77% | -1.98% | 7.71% | 14.29% | Upgrade
|
| D&A For EBITDA | 85 | 64.57 | 79.87 | 79.74 | 78.43 | Upgrade
|
| EBIT | 138 | 96.96 | -108.08 | 32.83 | 143.75 | Upgrade
|
| EBIT Margin | 8.21% | 5.87% | -7.60% | 2.25% | 9.24% | Upgrade
|
| Effective Tax Rate | 55.56% | 125.08% | - | 36.60% | 27.66% | Upgrade
|
| Advertising Expenses | - | 56.75 | 41.89 | 40.43 | 35.98 | Upgrade
|
Updated Nov 17, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.